Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Equity (2016 - 2026)

Ani Pharmaceuticals' Return on Equity history spans 15 years, with the latest figure at 0.0% for Q4 2025.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Equity hit 0.0% in Q4 2025 for Ani Pharmaceuticals, down from 0.0% in the prior quarter.
  • Over the last five years, Return on Equity for ANIP hit a ceiling of 93.92% in Q4 2023 and a floor of 263.24% in Q1 2023.
  • Historically, Return on Equity has averaged 11.01% across 5 years, with a median of 0.0% in 2025.
  • Biggest five-year swings in Return on Equity: crashed -26364bps in 2023 and later soared 26332bps in 2024.
  • Tracing ANIP's Return on Equity over 5 years: stood at 0.0% in 2021, then soared by 47bps to 0.0% in 2022, then soared by 3916309bps to 93.92% in 2023, then plummeted by -100bps to 0.0% in 2024, then skyrocketed by 255bps to 0.0% in 2025.
  • Business Quant data shows Return on Equity for ANIP at 0.0% in Q4 2025, 0.0% in Q3 2025, and 51.03% in Q2 2025.